- Previous Close
78.10 - Open
78.10 - Bid 77.80 x --
- Ask 78.00 x --
- Day's Range
76.80 - 78.30 - 52 Week Range
69.20 - 124.00 - Volume
348,332 - Avg. Volume
878,035 - Market Cap (intraday)
7.403B - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
250.97 - EPS (TTM)
0.31 - Earnings Date --
- Forward Dividend & Yield 1.00 (1.28%)
- Ex-Dividend Date Jun 7, 2024
- 1y Target Est
--
Ever Fortune.AI Co., Ltd., an cloud-based biomedical platform, provides medical artificial intelligence solutions and services in China. The company offers radiation therapy organ, head and neck organ delineation system, bone scintigraphy computer-aided detection platform, cerebral hemorrhage detection system, myocardial perfusion image analysis and reporting system, ECG analysis software, acute aortic syndrome, detection system, acute myocardial infarction detection software, heart-to-chest ratio estimation system, artificial intelligence assisted chest X-ray diagnosis system, bone age auxiliary diagnosis system, and image recording and transmission system. Ever Fortune.AI Co., Ltd. was founded in 1998 and is based in Taichung City, Taiwan. Ever Fortune.AI Co., Ltd. is a subsidiary of An Ji Biomedical Corporation.
www.everfortuneai.com.tw--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6841.TWO
View MorePerformance Overview: 6841.TWO
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6841.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6841.TWO
View MoreValuation Measures
Market Cap
7.40B
Enterprise Value
6.45B
Trailing P/E
250.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
22.54
Price/Book (mrq)
3.96
Enterprise Value/Revenue
19.12
Enterprise Value/EBITDA
82.78
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.35%
Return on Assets (ttm)
-0.75%
Return on Equity (ttm)
-0.09%
Revenue (ttm)
277.66M
Net Income Avi to Common (ttm)
-3.75M
Diluted EPS (ttm)
0.31
Balance Sheet and Cash Flow
Total Cash (mrq)
975.37M
Total Debt/Equity (mrq)
0.34%
Levered Free Cash Flow (ttm)
-42.69M